Cedar-Sinai's Melmed Named to CIRM Board

Shlomo Melmed 

The governing board for the $3 billion California stem cell agency has a new member – Shlomo Melmed, who is senior vice president for academic affairs and dean of the medical faculty at Cedars-Sinai Medical Center in Los Angeles.

Gov. Arnold Schwarzenegger named Melmed to replace Ricardo Azziz, who left California to head the Medical College of Georgia. Azziz was also a top executive at Cedars-Sinai.

The Cedars news release last week on the appointment said,

“Melmed, the Helene A. and Philip E. Hixon Chair in Investigative Medicine at Cedars-Sinai, is an internationally recognized endocrinologist and specialist in pituitary disorders. His research, which is primarily focused on the regulation of growth hormones and causes and treatments of pituitary tumors, has impacted endocrine care worldwide, and has consistently been funded by the National Institutes of Health since 1980.

“He has authored more than 300 articles in prestigious peer-reviewed journals, trained more than 60 physicians, scientists and graduate students, and played a major role in leading the growth of research and educational programs at Cedars-Sinai.”

Melmed is also professor and associate dean at the UCLA School of Medicine.

(Cedars-Sinai photo)